BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25465716)

  • 1. Clinical characteristics and prognostic factors of bone lymphomas: focus on the clinical significance of multifocal bone involvement by primary bone large B-cell lymphomas.
    Wu H; Bui MM; Leston DG; Shao H; Sokol L; Sotomayor EM; Zhang L
    BMC Cancer; 2014 Dec; 14():900. PubMed ID: 25465716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of soft tissue extension, international prognostic index, and multifocality in primary bone lymphoma: a single institutional experience.
    Wu H; Zhang L; Shao H; Sokol L; Sotomayor E; Letson D; Bui MM
    Br J Haematol; 2014 Jul; 166(1):60-8. PubMed ID: 24673481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the IELSG 14 study).
    Messina C; Ferreri AJ; Govi S; Bruno-Ventre M; Gracia Medina EA; Porter D; Radford J; Heo DS; Park HY; Pro B; Jayamohan J; Visco C; Scarfò L; Zucca E; Gospodarowicz M; Christie D;
    Br J Haematol; 2014 Mar; 164(6):834-40. PubMed ID: 24383942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical characteristics and outcomes of 31 patients with primary bone lymphoma].
    Zhu Y; Yue C; Wu B; Ping B
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Mar; 33(3):444-7. PubMed ID: 23529250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary bone lymphoma: a new and detailed characterization of 28 patients in a single-institution study.
    Maruyama D; Watanabe T; Beppu Y; Kobayashi Y; Kim SW; Tanimoto K; Makimoto A; Kagami Y; Terauchi T; Matsuno Y; Tobinai K
    Jpn J Clin Oncol; 2007 Mar; 37(3):216-23. PubMed ID: 17472971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of concordant and discordant bone marrow involvement and cell-of-origin in Korean patients with diffuse large B-cell lymphoma treated with R-CHOP.
    Park MJ; Park SH; Park PW; Seo YH; Kim KH; Seo JY; Jeong JH; Kim MJ; Ahn JY; Hong J
    J Clin Pathol; 2015 Sep; 68(9):733-8. PubMed ID: 25998512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Bone Lymphoma: A Clinical Analysis of 17 Patients in a Single Institution.
    Hayase E; Kurosawa M; Suzuki H; Kasahara K; Yamakawa T; Yonezumi M; Suzuki S; Teshima T
    Acta Haematol; 2015; 134(2):80-5. PubMed ID: 25895753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Clinical Features Between Primary and Secondary Breast Diffuse Large B Cell Lymphoma: A Yokohama Cooperative Study Group for Hematology Multicenter Retrospective Study.
    Takahashi H; Sakai R; Sakuma T; Matsumura A; Miyashita K; Ishii Y; Nakajima Y; Numata A; Hattori Y; Miyazaki T; Hashimoto C; Koharazawa H; Takemura S; Taguchi J; Fujimaki K; Fujita H; Nakajima H
    Indian J Hematol Blood Transfus; 2021 Jan; 37(1):60-66. PubMed ID: 33707836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components.
    Li X; Xia B; Guo S; Zhan Z; Zhang L; Zhao D; Wu X; Zhang Y
    Ann Hematol; 2013 Jun; 92(6):807-15. PubMed ID: 23417758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma.
    Tao R; Allen PK; Rodriguez A; Shihadeh F; Pinnix CC; Arzu I; Reed VK; Oki Y; Westin JR; Fayad LE; Medeiros LJ; Dabaja B
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):122-9. PubMed ID: 25754633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of the 5' noncoding region of the BCL-6 gene in primary bone lymphomas.
    Gianelli U; Ponzoni M; Moro A; Alfano RM; Pellegrini C; Giardini R; Patriarca C; Armiraglio E; Bosari S; Parafioriti A; Coggi G
    Ann Hematol; 2003 Nov; 82(11):691-5. PubMed ID: 14513282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic features of the nine patients with primary diffuse large B cell lymphoma of the breast.
    Seker M; Bilici A; Ustaalioglu BO; Yilmaz B; Ozturk B; Ünal A; Dane F; Ozdemir NY; Elkiran ET; Kalender ME; Gumus M; Benekli M
    Arch Gynecol Obstet; 2011 Aug; 284(2):405-9. PubMed ID: 20872226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of concordant and discordant cytomorphology of bone marrow involvement in patients with diffuse, large, B-cell lymphoma treated with R-CHOP.
    Shim H; Oh JI; Park SH; Jang S; Park CJ; Huh J; Suh C; Chi HS
    J Clin Pathol; 2013 May; 66(5):420-5. PubMed ID: 23610041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
    Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
    Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphomas of the bone: a pathological and clinical study of 54 cases.
    Gianelli U; Patriarca C; Moro A; Ponzoni M; Giardini R; Massimino M; Alfano RM; Armiraglio E; Nuciforo P; Bosari S; Coggi G; Parafioriti A
    Int J Surg Pathol; 2002 Oct; 10(4):257-66. PubMed ID: 12490975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of dendritic cell marker CD21 is a positive prognostic factor in diffuse large B-cell lymphoma].
    Yao WK; Wang YP; Peng F; Zheng Y; Zou YB; Gao JN; Liu XL
    Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):818-22. PubMed ID: 23324230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary bone lymphoma: treatment results and prognostic factors with long-term follow-up of 82 patients.
    Beal K; Allen L; Yahalom J
    Cancer; 2006 Jun; 106(12):2652-6. PubMed ID: 16700039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric primary bone lymphoma-diffuse large B-cell lymphoma: morphologic and immunohistochemical characteristics of 10 cases.
    Zhao XF; Young KH; Frank D; Goradia A; Glotzbecker MP; Pan W; Kersun LS; Leahey A; Dormans JP; Choi JK
    Am J Clin Pathol; 2007 Jan; 127(1):47-54. PubMed ID: 17145622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High total metabolic tumor volume in PET/CT predicts worse prognosis in diffuse large B cell lymphoma patients with bone marrow involvement in rituximab era.
    Song MK; Yang DH; Lee GW; Lim SN; Shin S; Pak KJ; Kwon SY; Shim HK; Choi BH; Kim IS; Shin DH; Kim SG; Oh SY
    Leuk Res; 2016 Mar; 42():1-6. PubMed ID: 26851438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary diffuse large B-cell lymphomas of the bone: prognostic relevance of protein expression and clinical factors.
    Adams H; Tzankov A; d'Hondt S; Jundt G; Dirnhofer S; Went P
    Hum Pathol; 2008 Sep; 39(9):1323-30. PubMed ID: 18614198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.